Skip to main content
. 2018 Jul 30;13(7):e0200017. doi: 10.1371/journal.pone.0200017

Table 1. Characteristics of eligible 2,714 participants in the Framingham Offspring Study.

Values are represented in percentage unless otherwise indicated.

Characteristics 3rd exam
(pre-baseline; 1984–1987)
4th exam
(baseline; 1987–1991)
5th exam
(1991–1994)
6th exam
(1994–1998)
7th exam
(1998–2001)
Current smoker 27.5 23.0 19.1 14.9 12.2
Cigarettes per day among smokers, mean (SD) 22.9 (12.9) 21.9 (12.6) 21.1 (12.0) 19.9 (11.7) 18.3 (11.3)
Alcoholic drinks per day
 None 27.6 29.8 30.2 36.8 33.7
 >0 to <2 54.2 55.5 55.3 53.2 52.9
 2 to <4 13.9 11.3 11.7 8.6 10.8
 4 or more 4.3 3.4 2.9 1.4 2.6
Body mass index (kg/m2); mean (SD) 26 (4.6) 26.6 (4.8) 27.3 (4.9) 27.8 (5.2) 28.1 (5.3)
Diabetes 2.7 3.9 6.3 9.6 12.3
Systolic blood pressure (mmHg); median (IQR) 121 (111, 132) 124 (112, 137) 124 (112.5, 137) 126 (114, 138.5) 125 (114, 138)
Systolic blood pressure categories
 <120 mmHg (Low) 45.8 40.5 40.2 34.3 34.1
 120 to <140 mmHg (Pre-hypertension) 40.6 38.6 38.6 39.3 37.5
 140 to <160 mmHg (Stage 1 hypertension) 11.0 16.1 16.4 16.2 15.5
 ≥160 mmHg (Stage 2 hypertension) 2.6 4.9 4.9 6.0 5.2
LDL-cholesterol (mg/dL); median (IQR) 133 (110.2, 158.6) 130.6 (107, 156.2) 125.4 (104.4, 148.6) 125 (104.8, 147.8) 119.2 (98.4, 141)
LDL-cholesterol categories
 <130 mg/dL (low) 46.3 49.2 53.7 52.7 56.6
 130 to <160 mg/dL (moderate) 29.7 29.8 29.8 26.8 22.4
 160 to <190 mg/dL (high) 16.8 15.6 11.5 11.3 8.2
 ≥190 mg/dL (very high) 7.2 5.4 3.8 3.6 2.1
Blood pressure medication 13.5 15.1 16.3 25.6 32.6
Lipid-lowering medication 0.7 2.6 5.7 10.8 18.7